Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences
- PMID: 22252887
- DOI: 10.1002/stem.1035
Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences
Abstract
There is increasing evidence that a variety of cancers arise from transformation of normal stem cells to cancer stem cells (CSCs). CSCs are thought to sustain cancer progression, invasion, metastasis, and recurrence after therapy. Reports suggest that CSCs are highly resistant to conventional therapy. Emerging evidences show that the chemoresistance of CSCs are in part due to the activation of B cell-specific Moloney murine leukemia virus integration site 1 (BMI1), a stem cell factor, and a polycomb group family member. BMI1 is reported to regulate the proliferation activity of normal, stem, and progenitor cells. BMI1 plays a role in cell cycle, cell immortalization, and senescence. Numerous studies demonstrate that BMI1, which is upregulated in a variety of cancers, has a positive correlation with clinical grade/stage and poor prognosis. Although evidences are in support of the role of BMI1 as a factor in chemoresistance displayed by CSCs, its mechanism of action is not fully understood. In this review, we provide summary of evidences (with mechanism of action established) suggesting the significance of BMI1 in chemoresistance and recurrence of CSCs.
Copyright © 2012 AlphaMed Press.
Similar articles
-
Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance.Chang Gung Med J. 2011 May-Jun;34(3):229-38. Chang Gung Med J. 2011. PMID: 21733352 Review.
-
Bmi1 promotes hepatic stem cell expansion and tumorigenicity in both Ink4a/Arf-dependent and -independent manners in mice.Hepatology. 2010 Sep;52(3):1111-23. doi: 10.1002/hep.23793. Hepatology. 2010. PMID: 20648475
-
Polycomb group protein Bmi1 promotes hematopoietic cell development from embryonic stem cells.Stem Cells Dev. 2012 Jan;21(1):121-32. doi: 10.1089/scd.2010.0539. Epub 2011 Jun 17. Stem Cells Dev. 2012. PMID: 21545235
-
The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.Cancer Res. 2008 Oct 1;68(19):7742-9. doi: 10.1158/0008-5472.CAN-07-5882. Cancer Res. 2008. PMID: 18829528
-
Role of the polycomb group gene BMI1 in normal and leukemic hematopoietic stem and progenitor cells.Curr Opin Hematol. 2010 Jul;17(4):294-9. doi: 10.1097/MOH.0b013e328338c439. Curr Opin Hematol. 2010. PMID: 20308890 Review.
Cited by
-
CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.BMC Med Genomics. 2022 Oct 31;15(1):225. doi: 10.1186/s12920-022-01383-w. BMC Med Genomics. 2022. PMID: 36316684 Free PMC article.
-
Genomics-Guided Drawing of Molecular and Pathophysiological Components of Malignant Regulatory Signatures Reveals a Pivotal Role in Human Diseases of Stem Cell-Associated Retroviral Sequences and Functionally-Active hESC Enhancers.Front Oncol. 2021 Mar 31;11:638363. doi: 10.3389/fonc.2021.638363. eCollection 2021. Front Oncol. 2021. PMID: 33869024 Free PMC article.
-
Biomarkers in Colorectal Cancer: Current Research and Future Prospects.Int J Mol Sci. 2020 Jul 27;21(15):5311. doi: 10.3390/ijms21155311. Int J Mol Sci. 2020. PMID: 32726923 Free PMC article. Review.
-
Polycomb group proteins and MYC: the cancer connection.Cell Mol Life Sci. 2014 Jan;71(2):257-69. doi: 10.1007/s00018-013-1426-x. Epub 2013 Jul 30. Cell Mol Life Sci. 2014. PMID: 23897499 Free PMC article. Review.
-
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis.J Hematol Oncol. 2022 Sep 8;15(1):129. doi: 10.1186/s13045-022-01347-8. J Hematol Oncol. 2022. PMID: 36076302 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
